| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PNAS..109E2476C |
| P356 | DOI | 10.1073/PNAS.1205459109 |
| P932 | PMC publication ID | 3443147 |
| P698 | PubMed publication ID | 22895790 |
| P5875 | ResearchGate publication ID | 235611259 |
| P50 | author | David E Solow-Cordero | Q55168151 |
| Ron Geller | Q38327679 | ||
| P2093 | author name string | Carmel T Chan | |
| Sanjiv S Gambhir | |||
| Tarik F Massoud | |||
| Ramasamy Paulmurugan | |||
| Gabriela Chiosis | |||
| Shahriar S Yaghoubi | |||
| Aileen Hoehne | |||
| Robert E Reeves | |||
| P2860 | cites work | Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 |
| Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation | Q24655658 | ||
| Expressional patterns of chaperones in ten human tumor cell lines. | Q24798540 | ||
| Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers | Q27022514 | ||
| Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90. | Q40541755 | ||
| Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice | Q40547190 | ||
| A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors | Q40631570 | ||
| Involvement of human heat shock protein 90 alpha in nicotine-induced apoptosis | Q40718591 | ||
| Rapid engineering of the geldanamycin biosynthesis pathway by Red/ET recombination and gene complementation | Q41819468 | ||
| High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity | Q44820201 | ||
| Radicicol, a heat shock protein 90 inhibitor, reduces glomerular filtration rate | Q46454774 | ||
| Synthesis of a red-shifted fluorescence polarization probe for Hsp90. | Q50730634 | ||
| A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer. | Q53496592 | ||
| Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors | Q80048527 | ||
| Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancer | Q80633170 | ||
| Differential expression of Hsp90 isoforms in geldanamycin-treated 9L cells | Q83186233 | ||
| Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site | Q28205041 | ||
| Targeting the dynamic HSP90 complex in cancer | Q28288602 | ||
| Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase | Q31108274 | ||
| Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries | Q33251617 | ||
| Hsp90 and co-chaperones twist the functions of diverse client proteins | Q33607477 | ||
| Expression of hsp90 and cyclin D1 in human breast cancer | Q33865601 | ||
| Optical imaging of Renilla luciferase reporter gene expression in living mice | Q33897818 | ||
| Heat shock protein 90: inhibitors in clinical trials. | Q34091401 | ||
| Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects | Q34096497 | ||
| Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice | Q34134401 | ||
| Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts | Q34164724 | ||
| Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET. | Q34164758 | ||
| Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90 | Q34267905 | ||
| Hsp90: a novel target for cancer therapy | Q34547609 | ||
| Update on Hsp90 inhibitors in clinical trial. | Q35009729 | ||
| Development of Radicicol Analogues | Q35551879 | ||
| Heat shock protein 90. | Q35587293 | ||
| Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses | Q35674485 | ||
| Targeting multiple signal transduction pathways through inhibition of Hsp90. | Q35787276 | ||
| Targeting chaperones in transformed systems--a focus on Hsp90 and cancer | Q36379365 | ||
| Discovery and development of purine-scaffold Hsp90 inhibitors | Q36536332 | ||
| Discovery and development of pyrazole-scaffold Hsp90 inhibitors | Q36536337 | ||
| 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma | Q36628242 | ||
| Development and application of Hsp90 inhibitors | Q37055392 | ||
| Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. | Q37464549 | ||
| Molecular basis for the actions of Hsp90 inhibitors and cancer therapy | Q37910724 | ||
| A molecular imaging primer: modalities, imaging agents, and applications | Q38005672 | ||
| A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors | Q38338682 | ||
| Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM. | Q39597606 | ||
| (89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft | Q39758832 | ||
| Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model | Q40016083 | ||
| Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol | Q40206699 | ||
| Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90. | Q40435730 | ||
| Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90. | Q40538454 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E2476-85 | |
| P577 | publication date | 2012-08-15 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects | |
| P478 | volume | 109 |
| Q55397197 | A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells. |
| Q89026697 | Advances in bioluminescence imaging: new probes from old recipes |
| Q90588942 | Building Biological Flashlights: Orthogonal Luciferases and Luciferins for in Vivo Imaging |
| Q35769802 | In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs |
| Q26851635 | Luciferase fragment complementation imaging in preclinical cancer studies |
| Q48118580 | Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development |
| Q42177727 | Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters. |
| Q51752072 | Progress and prospects for targeting Hsp90 to treat fungal infections. |
| Q35044051 | Syntheses and discovery of a novel class of cinnamic hydroxamates as histone deacetylase inhibitors by multimodality molecular imaging in living subjects |
| Q38234720 | Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease |
Search more.